Janus kinase inhibitors (JAKi) for the treatment of atopic dermatitis: real-life data on efficacy and safety in light of the Pharmacovigilance Risk Assessment Committee (PRAC) recommended measures.

Z Reguiai,P A Becherel, A C Fougerousse, G Chaby, J L Perrot, E Begon, C Jacobzone-Lévêque, C Boulard, A Badaoui, C Poreaux, L David, N Quiles-Tsimaratos, D Lons-Danic, C Fite, A-L Liegeon, A Patchinsky, J Parier, C Garcia, E Estève, R Mohty, L Mery-Bossard,F Maccari

Journal of the European Academy of Dermatology and Venereology : JEADV（2023）

引用 0|浏览4

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要